PFAS linked to infertility, diabetes and billions in economic costs

Researchers have found strong evidence exposure to a common group of household chemicals can be associated with 13 different health conditions. The related economic costs have been estimated at between US$5 billion and $60 billion annually in the US.

Source of Article

Continue ReadingPFAS linked to infertility, diabetes and billions in economic costs

Large study estimates risks and prevalence of long COVID in children

New research published in JAMA Network Open offers new insights into the risk children face from long COVID. The findings reveal long COVID is relatively rare in children, and most prevalent in hospitalized adolescents over the age of 14.

Source of Article

Continue ReadingLarge study estimates risks and prevalence of long COVID in children

Monkeypox declared global health emergency, 72 child cases reported

The World Health Organization has declared the monkeypox outbreak a Public Health Emergency of International Concern. The outbreak has now spread to 75 countries with more than 16,000 cases officially recorded, 72 of which have been seen in children.

Source of Article

Continue ReadingMonkeypox declared global health emergency, 72 child cases reported

Higher rates of antibiotic-resistant bacteria in dogs fed raw meat

A pair of new studies from researchers in the UK offer a warning to dog owners who frequently feed their pets raw meat. The research indicates pets fed raw meat diets were more likely to harbor antibiotic-resistant bacteria.

Source of Article

Continue ReadingHigher rates of antibiotic-resistant bacteria in dogs fed raw meat

Music shows promising potential for slowing the progression of dementia

A fascinating new study has offered novel insights into what happens in your brain when you rock out to your favorite songs. And the findings raise some intriguing possibilities for unique dementia treatments in the future.

Source of Article

Continue ReadingMusic shows promising potential for slowing the progression of dementia

Oxford study investigates the most effective drugs for insomnia

A study has reviewed more than 150 clinical trials to present a comparative analysis of 30 drug treatments for insomnia. The findings indicate many lack long-term safety data and treatments such as melatonin have little evidence of effectiveness.

Source of Article

Continue ReadingOxford study investigates the most effective drugs for insomnia

Another study ties Alzheimer’s progression to bacteria in your mouth

A common type of oral bacteria associated with periodontal disease has been linked to neuroinflammation and the progression of Alzheimer’s disease. The research builds on a prior evidence linking poor oral health with dementia and neurodegeneration.

Source of Article

Continue ReadingAnother study ties Alzheimer’s progression to bacteria in your mouth

“Hangover pill” goes on sale in UK – but here’s the problem with Myrkl

A new Swedish "pre-drinking pill" went on sale in the UK today. Widely referred to as the "hangover pill," the optimistically-named Myrkl is claimed to break down alcohol before it reaches the liver, preventing the formation of toxic acetaldehyde.

Source of Article

Continue Reading“Hangover pill” goes on sale in UK – but here’s the problem with Myrkl

Nicotine-salt e-cig pods may harm immune cells more than other vapes

New research has found users of nicotine-salt-containing pod and disposable e-cigarettes display unique markers of immune suppression not seen in users of other kinds of e-cigarettes. The study indicates the long-term health implications are unknown.

Source of Article

Continue ReadingNicotine-salt e-cig pods may harm immune cells more than other vapes

FDA and WHO disagree on COVID-19 vaccine booster variant advice

Over the last few weeks the FDA and the WHO have disagreed over what direction COVID-19 vaccines should take later this year. Which Omicron subtype should boosters focus on, and how quickly can vaccine makers deliver new doses?

Source of Article

Continue ReadingFDA and WHO disagree on COVID-19 vaccine booster variant advice